key: cord-0687443-c6td4uhr authors: Uwishema, Olivier; Adanur, Irem; Babatunde, Abdulhammed Opeyemi; Hasan, Mohammad Mehedi; Elmahi, Osman Kamal Osman; Olajumoke, Kolawole Barakat; Aborode, Abdullahi Tunde; Emmanuella, Nzeribe; Costa, Ana Carla dos Santos; Ahmad, Shoaib; Essar, Mohammad Yasir title: Viral infections amidst COVID‐19 in Africa: Implications and recommendations date: 2021-07-22 journal: J Med Virol DOI: 10.1002/jmv.27211 sha: 22b17b45f6fb16a1eae7334515996a67888bac95 doc_id: 687443 cord_uid: c6td4uhr Viral infections have been on the rise for the past decades. The impact of the viruses worsened amidst the pandemic burdening the already overwhelmed health care system in African countries. This article sheds light on how the coronavirus together with the already existing viral infections, some of which re‐emerged, impacted the continent. The strategies in place such as immunization, education, will have to be strengthened in all African countries to reduce the burden. Furthermore, governments can further collaborate with other countries in creating guidelines to reduce co‐infection of the diseases. sponsible for the recent outbreaks of Ebola on the continent. 2 The existence of numerous endemic viral diseases contributes to the overload in the health system of African countries as there is also a need to deal with simultaneous and frequent outbreaks of potentially fatal diseases. With the recent outbreak of coronavirus disease 2019 (COVID-19), a new burden has been added to the already fragile structure of the African health system, especially that the region has already been dealing with significant sanitary issues and concerns. Hence, this paper aims to discuss the implications of viral infections amidst COVID-19 in Africa and, ultimately, to present recommendations. To fight infectious diseases, local and international health programs set three main objectives, which include: awareness campaigns, early diagnosis, and effective treatment. 3 These targets help eradicate viruses and limit their spread, especially in the populous Africa, whose health system is not only feeble but has also been suffering a lot. For instance, even before the pandemic, Africa had a limited health workforce already. When COVID-19 achieved a "pandemic" status from the World Health Organization (WHO), 3 the limited number of healthcare workers and resources in Africa had to be redirected to respond to this new threat. Hence, the pandemic has intensified the difficulty in accessing health services and has also negatively affected the surveillance, testing, treatment, and vaccination measures for other infectious diseases. In turn, this can reverse the progress made so far in reducing the prevalence and mortality from these fatal viral infections. Similar behavior has been observed in other parts of the world, such as Guinea, Brazil, India, Pakistan, and Afghanistan, where the pandemic has negatively affected the epidemiological surveillance of endemic infectious diseases like Ebola, 4 dengue, 5, 6 chikungunya, 7 Zika, 8 polio, 9,10 and typhoid. 11 Meanwhile, even though models predicting a massive COVID-19 spread in Africa turned less efficient than expected, the outcome was otherwise more accurate when it comes to studying the spread of other viruses as the new global pandemic worsened various infectious diseases across the sub-Saharan region. 12 One of the main reasons is that due to national lockdowns, mass population immunization had to be halted at first, which increased the risk of a new surge in the existing infectious illnesses. 13 The COVID-19 pandemic also made an impact on the management of chronic viral diseases such as HIV. It is estimated that over the coming year (2020-2021), a six-month complete interruption in HIV response could result in more than 500 000 fatalities in Sub-Saharan Africa. 14 Moreover, at the beginning of the pandemic, many scientists and international institutions feared that with the imposed lockdowns and the concerns of catching the coronavirus, ill people would have difficulties getting their regular treatment. These concerns turned true, as several reports showed that about 13% to even 50% of people could not get their medications in South Africa, Kenya, and Nigeria as of May 2020. 12, 13, 15 In Zimbabwe, patients usually would not be able to get a refill for their antiretroviral drug against HIV infection. 16 In fact, the World Health Organization confirmed that last 2020, five countries in sub-Saharan Africa where the HIV treatment stock was sufficient to only 3 months or less. Even though these declines were later recuperated in July during that same year, and HIV patients taking treatment in 2020 were slightly higher than in 2019, 17 recent studies have shown that antiretroviral medication initiations and HIV testing decreased sharply by 50% in April, with only a slight improvement over the next months, never reaching their pre-lockdown levels. 17, 18 The Central African Republic adopted an extensive National HIV Strategic Plan 2021-2025 in 2020, with the goal of eliminating inequality, halving HIV Infections, and ensuring that 95% of HIV patients have the therapeutic benefit of ART by 2025. 19 Meanwhile, UNAIDS' 2020 targets were to: (a) newly diagnose 1.1 million people that have HIV; (b) provide 3 million additional patients on treatment; and, (c) help also 3 million people achieve viral suppression. 17 Although the last mentioned target was somehow accomplished by keeping patients on their regular medications, the first two were not fully attained. These failures can be explained by different causes. First, resources and healthcare workers were diverted from the HIV departments to the COVID-19 to help fight the pandemic. For example, in South Africa, 28,000 HIV employees changed positions. 18 Moreover, the lack of large centers enabling social distancing, the reduced staff and operation times among most establishments, as well as the challenges involved in attending facilities during lockdowns from transport struggles to high costs and scarce resources, have made people less engaged to refer to the clinics and seek help. 18 In consequence, the United Nations program to fight AIDS has failed more than what was expected, bringing back the situation and making it miss its 90-90-90 goal for the year 2020. However, it is worth noting that the findings suggest that worse projected studies did not play out and large disruptions in HIV management did not happen; hence, HIV morbidity and mortality were not highly affected. 18 On the other hand, other contagious infectious diseases were Meanwhile, among the main reasons for Ebola and Lassa Fever outbreaks in the region is the socioeconomic downturn due to COVID-19, which has also affected the surveillance and treatment of patients infected within countries where they are prevalent. In addition, swift case detection and contact tracing are paramount for surveillance for these viral infections, especially the Ebola virus which has been noted to be similar to COVID-19. 24 However, lessons learned in previous outbreaks, such as the Ebola outbreak in the Democratic Republic of Congo, have been efficient in guiding response to COVID-19 in these countries. 25 There is also a relatively higher seroprevalence of arboviruses, like dengue in Africa, compared to the number of reported outbreaks, as cases go undetected owing to the poor public health systems in many African countries. 26 This could also be the case for other viral infections, as public health attention is mainly on COVID-19 surveillance and vaccination. Furthermore, many other local viruses with no big outbreaks are being fought all over the African countries, leaving the continent with a high disease burden. Africa is a high-risk area for the spread of viral diseases mainly due to overpopulation, poverty, under-resourced health care system, inadequate healthcare workforce, low testing capacities, and poor surveillance system present in the region. Of 25 countries highly exposed to infectious diseases reported by Infectious Disease Vulnerability Index in 2016, 22 were from the African region. 27 According to WHO Africa, 213 million Africans are infected with malaria, 71 million with hepatitis B and C, 2.5 million with tuberculosis, and 26 million with HIV. [28] [29] [30] [31] Owing to the combined effects of these infectious diseases, coupled with the recent emergence of the COVID-19 pandemic in Africa, health systems in the region are experiencing a major burden from these infectious diseases. As focus shifts to COVID-19 management, data on viral infec- For instance, COVID-19, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a disease characterized predominantly by the involvement of the lower respiratory tract-with fever and neurological damage (or mental status alteration) as some of its clinical findings Such signs and symptoms from a patient may coincide with other viral infections common in the continent such as yellow fever, 32 dengue, and tick-borne encephalitis which may further cause confusion and delay of the necessary and appropriate treatment methods. 33 Ultimately, this can aggravate the current health condition of the patient, which may lead to unfavorable clinical outcomes and worse prognosis, especially when the patient is confirmed to have the SARS-CoV-2 infection while suffering from another underlying disease such as HIV-AIDS. In response to the challenges brought about by the coexistence of COVID-19 and other viral infections in the African regions, the following are therefore recommended: (1) Strengthen the call for immunization against common viral infections, including COVID-19. (2) Promote awareness and education on the benefits of vaccination, especially among the vulnerable populations. F I G U R E 1 A summary of challenges and recommendations to combat viral infections amid the COVID-19 pandemic in Africa Systematic review of important viral diseases in africa in light of the 'one health' concept Knowledge and risk perception towards Lassa fever infection among residents of affected communities in Ebonyi State, Nigeria: implications for risk communication who-director-general-s-opening-remarks-at-the-mediabriefing-on-covid Ebola outbreak amid COVID-19 in the Republic of Guinea: priorities for achieving control Dengue amidst COVID-19 in India: The mystery of plummeting cases Dengue and COVID-19: A double burden to Brazil Chikungunya and COVID-19 in Brazil: The danger of an overlapping crises COVID-19 and Zika: An emerging dilemma for Brazil Perspective piece polio amidst COVID-19 in Pakistan: What are the efforts being made and challenges at hand? Polio in Afghanistan: the current situation amid COVID-19 A skeleton in the closet: The implications of COVID-19 on XDR strain of typhoid in Pakistan Yiba. HSRC Study on COVID-19 Coronavirus fears keep HIV, TB patients from medication UNAIDS report on the global AIDS epidemic shows that 2020 targets will not be met because of deeply unequal success; COVID-19 risks blowing HIV progress way off course International AIDS Society. COVID-19 DSD Resources Community responses and perspectives The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis Central African Republic: producing HIV estimates in the context of crisis Deaths from Democratic Republic of the Congo measles outbreak top 6000 Measles is on the rise-and COVID-19 could make it worse Forty-two years of responding to ebola virus outbreaks in Sub-Saharan Africa: a review Recommendations for the COVID-19 response at the national level based on lessons learned from the ebola virus disease outbreak in the Democratic Republic of the Congo Dengue virus infection in people residing in Africa: a systematic review and meta-analysis of prevalence studies COVID-19 cases top 10 000 in Africa Message of WHO Regional Director for Africa World Hepatitis Day 2019-Message of WHO Regional Director for Africa World Tuberculosis Day World malaria report The spread of Yellow fever amidst the COVID-19 pandemic in Africa and the ongoing efforts to mitigate it Neurological manifestations in COVID-19 caused by SARS-CoV-2 Applications of telemedicine in the supply and distribution of COVID-19 vaccines in Africa Viral infections amidst COVID-19 in Africa: Implications and recommendations The authors declare that there are no conflict of interests.